Ellen Padrique
Pfizer (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Pharmacogenetics and Drug Metabolism, Lung Cancer Treatments and Mutations, Angiogenesis and VEGF in Cancer, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)(2011)909 cited
- → Mechanistic Effects of Autophosphorylation on Receptor Tyrosine Kinase Catalysis: Enzymatic Characterization of Tie2 and Phospho-Tie2(2001)38 cited
- → Structure activity relationships of quinoline-containing c-Met inhibitors(2007)20 cited